Hedge Fund - Palo Alto Investors
Acadia Pharmaceuticals Inc (ACAD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $44,247,794 | 8.43% | 2,663,925 | $18.17 |
| 2 | 2024 - Q4 (2024-12-31) | $50,436,792 | 7.81% | 2,748,599 | $16.14 |
| 3 | 2024 - Q3 (2024-09-30) | $38,818,443 | 5.04% | 2,523,956 | $16.68 |
| 4 | 2024 - Q2 (2024-06-30) | $39,306,166 | 4.55% | 2,418,841 | $16.14 |
| 5 | 2024 - Q1 (2024-03-31) | $44,652,296 | 5.03% | 2,414,943 | $24.78 |
| 6 | 2023 - Q4 (2023-12-31) | $75,443,198 | 6.79% | 2,409,556 | $23.88 |
| 7 | 2023 - Q3 (2023-09-30) | $50,136,726 | 4.74% | 2,405,793 | $27.16 |
| 8 | 2023 - Q2 (2023-06-30) | $57,618,742 | 4.65% | 2,405,793 | $22.23 |
| 9 | 2023 - Q1 (2023-03-31) | $45,277,024 | 3.75% | 2,405,793 | $19.05 |
| 10 | 2022 - Q4 (2022-12-31) | $37,831,794 | 3.22% | 2,376,369 | $15.63 |
| 11 | 2022 - Q3 (2022-09-30) | $27,455,000 | 2.17% | 1,678,196 | $16.19 |
| 12 | 2022 - Q2 (2022-06-30) | $23,646,000 | 2.06% | 1,678,196 | $18.68 |
| 13 | 2022 - Q1 (2022-03-31) | $54,539,000 | 4.21% | 2,251,834 | $24.20 |
| 14 | 2021 - Q4 (2021-12-31) | $54,566,000 | 3.48% | 2,337,877 | $20.11 |
| 15 | 2021 - Q3 (2021-09-30) | $38,832,000 | 2.34% | 2,337,877 | $19.28 |
| 16 | 2021 - Q2 (2021-06-30) | $57,021,000 | 3.14% | 2,337,877 | $22.57 |
| 17 | 2021 - Q1 (2021-03-31) | $60,317,000 | 3.43% | 2,337,877 | $44.02 |
| 18 | 2020 - Q4 (2020-12-31) | $123,037,000 | 6.44% | 2,301,477 | $49.64 |
| 19 | 2020 - Q3 (2020-09-30) | $75,582,000 | 4.14% | 1,832,300 | $43.18 |
| 20 | 2020 - Q2 (2020-06-30) | $75,851,000 | 4.55% | 1,564,900 | $48.00 |
| 21 | 2020 - Q1 (2020-03-31) | $68,932,000 | 5.77% | 1,631,524 | $41.20 |
| 22 | 2019 - Q4 (2019-12-31) | $81,512,000 | 4.48% | 1,905,374 | $43.50 |
| 23 | 2019 - Q3 (2019-09-30) | $78,339,000 | 5.21% | 2,176,677 | $30.32 |
| 24 | 2019 - Q2 (2019-06-30) | $61,714,000 | 3% | 2,308,803 | $25.54 |
| 25 | 2019 - Q1 (2019-03-31) | $60,370,000 | 2.51% | 2,248,403 | $23.35 |
| 26 | 2018 - Q4 (2018-12-31) | $32,761,000 | 1.74% | 2,026,063 | $19.42 |
| 27 | 2018 - Q3 (2018-09-30) | $34,964,000 | 1.41% | 1,684,180 | $15.73 |
| 28 | 2018 - Q2 (2018-06-30) | $25,207,000 | 1% | 1,650,780 | $17.83 |
| 29 | 2018 - Q1 (2018-03-31) | $37,093,000 | 1.58% | 1,650,780 | $27.69 |
| 30 | 2017 - Q4 (2017-12-31) | $49,411,000 | 2.12% | 1,641,030 | $31.98 |
| 31 | 2017 - Q3 (2017-09-30) | $61,818,000 | 2.6% | 1,641,030 | $32.53 |
| 32 | 2017 - Q2 (2017-06-30) | $44,996,000 | 2.1% | 1,613,330 | $29.80 |
| 33 | 2017 - Q1 (2017-03-31) | $54,679,000 | 2.58% | 1,590,430 | $35.30 |
| 34 | 2016 - Q4 (2016-12-31) | $44,184,000 | 2.52% | 1,532,030 | $26.46 |
| 35 | 2016 - Q3 (2016-09-30) | $47,140,000 | 2.73% | 1,481,930 | $33.90 |
| 36 | 2016 - Q2 (2016-06-30) | $46,669,000 | 3.52% | 1,437,730 | $33.47 |
| 37 | 2016 - Q1 (2016-03-31) | $13,563,000 | 1.05% | 485,100 | $21.84 |
The displayed share prices are average quarterly stock market prices.